|
Video: What is a Stock Split?
|
|
Zoetis is a holding company. Through its subsidiaries, Co. develops, manufactures and commercializes medicines, vaccines, diagnostic products and services, biodevices, genetic tests and animal health technology. Co.'s product categories include: vaccines, which are biological preparations that help prevent diseases of the respiratory, gastrointestinal and reproductive tracts or induce a specific immune response; and parasiticides, which are products that prevent or eliminate parasites. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services in biodevices, genetic tests and precision animal health. According to our ZTS split history records, Zoetis has had 0 splits. | |
|
Zoetis (ZTS) has 0 splits in our ZTS split history database.
Looking at the ZTS split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Zoetis shares, starting with a $10,000 purchase of ZTS, presented on a split-history-adjusted basis factoring in the complete ZTS split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/19/2024 |
|
Start price/share: |
$29.89 |
|
End price/share: |
$146.50 |
|
Starting shares: |
334.56 |
|
Ending shares: |
359.67 |
|
Dividends reinvested/share: |
$7.65 |
|
Total return: |
426.92% |
|
Average Annual Total Return: |
18.08% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$52,694.28 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/19/2024 |
|
Start price/share: |
$29.89 |
|
End price/share: |
$146.50 |
|
Dividends collected/share: |
$7.65 |
|
Total return: |
415.71% |
|
Average Annual Total Return: |
17.83% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$51,589.20 |
|
Years: |
10.00 |
|
|
|
|
|